Tempest Therapeutics
Price & Volume
Stats
See more52W Range | $3.01-$13.65 |
Market Cap | $14.2M |
Shares Short | 153,644 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$9.73 |
News
See moreYahoo Finance • 2 days ago
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
Yahoo Finance • 3 days ago
Tempest Therapeutics announces $8.35M registered direct offering, concurrent private placement
Yahoo Finance • 4 days ago
Butterfly Network, Citius Pharma Drive Biotech Momentum In After-Hours Trading
About
CEO | Mr. Stephen R. Brady J.D., LLM |
CFO | Mr. Nicholas Maestas |
Address | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 24 |
